ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CymaBay Therapeutics, Inc. (Nasdaq – CBAY), Everi Holdings Inc. (NYSE – EVRI), Sterling Check Corp. (Nasdaq – STER), Societal CDMO Check Corp. (Nasdaq – SCTL)

BALA CYNWYD, Pa., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

CymaBay Therapeutics, Inc. (Nasdaq – CBAY)

Under the terms of the agreement, CymBay will be acquired by Gilead Sciences, Inc. (Nasdaq - GILD). Gilead will acquire CymaBay for $32.50 per share in cash or a total equity value of $4.3 billion. The investigation concerns whether the CymaBay Therapeutics Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Gilead Sciences is paying fair value to shareholders of the Company.

Additional information can be found at https://www.brodskysmith.com/cases/cymabay-therapeutics-inc-nasdaq-cbay-2/.

Everi Holdings Inc. (NYSE – EVRI)

Under the terms of the Merger Agreement, Everi will merge with International Game Technology PLC (“IGT”) (NYSE - IGT). At closing, IGT shareholders are expected to own approximately 54% and Everi stockholders are expected to own approximately 46% of the shares in the combined company. The investigation concerns whether the Everi Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution to the Company’s shareholders in the combined company.

Additional information can be found at https://www.brodskysmith.com/cases/everi-holdings-inc-nyse-evri/.

Sterling Check Corp. (Nasdaq – STER)

Under the terms of the agreement, Sterling will be acquired by First Advantage Corporation (Nasdaq - FA). Sterling shareholders will elect to receive either $16.73 in cash or 0.979 shares of First Advantage common stock for each Sterling share. The shareholder election will be subject to proration, resulting in approximately 72% of Sterling’s shares being exchanged for cash consideration and 28% being exchanged for First Advantage common stock. The investigation concerns whether the Sterling Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the offer from First Advantage Corporation provides fair value to the Company’s shareholders.

Additional information can be found at https://www.brodskysmith.com/cases/sterling-check-corp-nasdaq-ster/.

Societal CDMO Check Corp. (Nasdaq – SCTL)

Under the terms of the agreement, Societal CDMO will be acquired by CoreRx, Inc. (“CoreRx”) for $1.10 per share in cash. The investigation concerns whether the Societal CDMO Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the offer from CoreRx provides fair value to the Company’s shareholders.

Additional information can be found at https://www.brodskysmith.com/cases/societal-cdmo-check-corp-nasdaq-ster/.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.


Primary Logo

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.